Société Relmada Therapeutics Inc OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Paolo Manfredi
FOU | Founder | 62 | 31/05/12 |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12/11/15 |
Charles Ence
CMP | Compliance Officer | 64 | 29/07/19 |
John Hixon
PRN | Corporate Officer/Principal | - | 21/07/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chairman | 78 | 14/07/15 | |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12/11/15 |
Fabiana Fedeli
BRD | Director/Board Member | 53 | 12/01/23 |
Director/Board Member | 61 | 19/12/19 | |
Paul Kelly
BRD | Director/Board Member | 65 | 12/11/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 30 174 202 | 27 748 959 ( 91,96 %) | 0 | 91,96 % |
Coordonnées société
Relmada Therapeutics, Inc.
2222 Ponce de Leon Boulevard 3rd floor
33134, Coral Gables
+786-629-1376
http://www.relmada.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+15,82% | 121 Md | |
+20,35% | 113 Md | |
+17,47% | 26,02 Md | |
-25,31% | 19,39 Md | |
-19,51% | 15,91 Md | |
-19,67% | 15,09 Md | |
-46,87% | 15,06 Md | |
+62,55% | 14,93 Md | |
+6,34% | 13,85 Md |
- Bourse
- Actions
- Action RLMD
- Action
- Société Relmada Therapeutics Inc